Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spironolactone and Dexamethasone in Patients Hospitalized With Moderate-to-severe COVID-19 (SPIDEX-II): a Randomized Clinical Trial

NCT04826822 is registered in ClinicalTrials.gov with Chita State Regional Clinical Hospital Number 1 as lead sponsor.

NCT NCT04826822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04826822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spironolactone and Dexamethasone in Patients Hospitalized With Moderate-to-severe COVID-19 (SPIDEX-II): a Randomized Clinical Trial
Lead sponsor
Chita State Regional Clinical Hospital Number 1
Phase
Phase 3
Overall status
Unknown status
Start date
February 24, 2021
Completion date
September 2, 2021
Enrollment
440 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, pneumonia, viral